PMV Pharmaceuticals, Inc.
Recent Filings
All 364 filings →| Form | Description | Date |
|---|---|---|
| 4 | — | Mar 9, 2026 |
| 4 | — | Mar 9, 2026 |
| 4 | — | Mar 9, 2026 |
| 4 | — | Mar 9, 2026 |
| S-8 | S-8 | Mar 6, 2026 |
| 8-K | 8-K | Mar 6, 2026 |
| 10-K | 10-K | Mar 6, 2026 |
| SCHEDULE 13D/A | — | Mar 4, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 9, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| OrbiMed Capital GP V LLC | — | Sale | 1,000,000 @ $1.52 | 4,975,291 | Oct 23, 2025 |
| ORBIMED ADVISORS LLC | — | Sale | 500,000 @ $1.80 | 5,975,291 | Sep 10, 2025 |
| Ticktin Robert | General Counsel & COO | Sale | 23,151 @ $1.06 | 98,695 | Jul 1, 2025 |
| Jalota Deepika | Chief Development Officer | Sale | 33,065 @ $1.06 | 89,959 | Jul 1, 2025 |
| Carulli Michael | Chief Financial Officer | Sale | 28,249 @ $1.06 | 60,146 | Jul 1, 2025 |
| Mack David Henry | President and CEO | Sale | 58,411 @ $1.06 | 536,133 | Jul 1, 2025 |
| Jalota Deepika | Chief Development Officer | Sale | 7,218 @ $1.50 | 118,283 | Sep 11, 2024 |
| Carulli Michael | Chief Financial Officer | Sale | 2,891 @ $1.50 | 88,395 | Sep 11, 2024 |
| Jalota Deepika | Chief Development Officer | Award / Grant | 95,555 | 125,501 | Jan 18, 2024 |
| Carulli Michael | Chief Financial Officer | Award / Grant | 82,220 | 91,286 | Jan 18, 2024 |